{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "March 2019: 54-year-old woman with an ECOG score of 1 presented with hoarseness and cough without an obvious cause. Enhanced chest CT scan revealed a nodule in the left upper lobe and mediastinal lymph node metastases in the pulmonary artery.",
        "clinical_data": {
          "functional_status": [
            {
              "domain": "ADLs",
              "description": "ECOG score of 1",
              "score": "1",
              "scale": "ECOG"
            }
          ],
          "HPI": [
            {
              "summary": "hoarseness and cough without an obvious cause",
              "onset": "March 2019",
              "associated_symptoms": [
                "C0019684",
                "C0010200"
              ]
            }
          ],
          "imaging": [
            {
              "type": "nodule",
              "body_part": "left upper lobe",
              "modality": "CT",
              "finding": "nodule in the left upper lobe and mediastinal lymph node metastases in the pulmonary artery",
              "date": "2019-03"
            },
            {
              "type": "metastases",
              "body_part": "mediastinal lymph node",
              "modality": "CT",
              "finding": "nodule in the left upper lobe and mediastinal lymph node metastases in the pulmonary artery",
              "date": "2019-03"
            }
          ]
        }
      }
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "Pathological diagnosis of lung adenocarcinoma via bronchoscopy. Brain MRI and whole-body bone scan showed no metastatic disease. Preliminary staging: cT2N2M0 IIIA.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C0294042",
              "label": "Adenocarcinoma of lung",
              "status": "active"
            }
          ],
          "imaging": [
            {
              "type": "Magnetic resonance imaging of brain",
              "body_part": "Brain",
              "modality": "MRI",
              "finding": "no metastatic disease"
            },
            {
              "type": "Bone scan",
              "body_part": "Whole body",
              "modality": "other",
              "finding": "no metastatic disease"
            }
          ],
          "procedures": [
            {
              "name": "Bronchoscopy",
              "outcome": "Pathological diagnosis of lung adenocarcinoma"
            }
          ]
        }
      }
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "Patient enrolled in a phase III clinical trial evaluating sintilimab as consolidation therapy for unresectable, locally advanced NSCLC (stage III) without disease progression after radical CCRT.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C34",
              "label": "Non-small cell lung cancer",
              "status": "active"
            }
          ],
          "procedures": [
            {
              "name": "Combined chemotherapy and radiation therapy",
              "approach": "other",
              "location": "lung",
              "outcome": "no disease progression"
            }
          ],
          "medications": [
            {
              "drug": "sintilimab",
              "modality": "IV",
              "indication": "Non-small cell lung cancer"
            }
          ]
        }
      }
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "Patient received two cycles of induction chemotherapy which ended in May 2019, followed by CCRT which ended in July 2019. CCRT consisted of 30 fractions of 2.0 Gy each, for a total of 60.0 Gy. The mean lung dose (MLD) was 13.5 Gy, with 17% of the lung receiving a dose of 20 Gy (V20) and 53% of the lung receiving a dose of 5 Gy (V5). Chest CT after CCRT showed a partial response (PR) (30.3% lesion reduction).",
        "clinical_data": {
          "medications": [
            {
              "drug": "Chemotherapy",
              "start_date": "2019-05",
              "end_date": "2019-05",
              "indication": "Cancer"
            }
          ],
          "procedures": [
            {
              "name": "Chemoradiotherapy",
              "date": "2019-07",
              "outcome": "Partial response"
            }
          ],
          "imaging": [
            {
              "type": "CT of chest",
              "body_part": "Lung",
              "modality": "CT",
              "finding": "Partial response",
              "date": "2019-07"
            }
          ]
        }
      }
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "Patient received consolidation sintilimab every 3 weeks. Three months after RT, during the third cycle of sintilimab treatment, the patient experienced pneumonitis with a slight cough, with imaging showing consolidation in the left lower lobe. Pneumonitis was diagnosed as a mild form of grade II RP.",
        "clinical_data": {
          "medications": [
            {
              "drug": "sintilimab",
              "dosage": null,
              "frequency": "every 3 weeks",
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": "consolidation"
            }
          ],
          "diagnoses": [
            {
              "code": null,
              "label": "pneumonitis",
              "status": "active",
              "onset_date": null
            }
          ],
          "imaging": [
            {
              "type": null,
              "body_part": "left lower lobe",
              "modality": null,
              "finding": "consolidation",
              "impression": null,
              "date": null
            }
          ],
          "HPI": [
            {
              "summary": "Patient experienced pneumonitis with a slight cough",
              "duration": null,
              "onset": null,
              "progression": null,
              "associated_symptoms": [
                "cough"
              ],
              "alleviating_factors": [],
              "exacerbating_factors": []
            }
          ]
        }
      }
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "Transition from initial presentation with hoarseness, cough, and lung nodule to pathological diagnosis of lung adenocarcinoma.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [
            "C0294042"
          ],
          "change_type": "addition",
          "target_domain": "diagnosis"
        }
      }
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "Transition from lung adenocarcinoma diagnosis to enrollment in a clinical trial evaluating sintilimab as consolidation therapy for unresectable, locally advanced NSCLC.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "sintilimab"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "Transition from enrollment in clinical trial to receiving induction chemotherapy and CCRT.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [
            "Chemoradiotherapy"
          ],
          "change_type": "addition",
          "target_domain": "procedure"
        }
      }
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "Transition from CCRT completion with partial response to experiencing pneumonitis during sintilimab treatment.",
        "transition_event": {
          "trigger_type": "symptom_onset",
          "trigger_entities": [
            "pneumonitis",
            "cough"
          ],
          "change_type": "addition",
          "target_domain": "symptom"
        }
      }
    }
  ]
}